DNLI DENALI THERAPEUTICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 18 analyst firms say about DENALI THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 6 months
Analyst view · last 6M
16 rated views · 19 analyst/firm records · 18 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #38 in the index87
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8073
Recent analyst activity · last 90 days
Our tracked history has 10 reports on DNLI from 9 analyst firms in the last 90 days (21 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target, 1 lowered it, 2 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Morgan Stanley raised its target from $36.00 (set 23 Jul 2026) to $42.00 on 4 Nov 2026.
Last 6 months. Latest opinion per identifiable analyst within the last 6 months. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Mayank Mamtani | Buy | 25 Aug 2026 | 35.00 USD |
| Baird | Daniel C Moore | Buy | 21 May 2026 | 34.00 USD |
| Baird | Joel Beatty | — | 7 Aug 2026 | 34.00 USD |
| Bernstein | Unnamed analyst | Hold | 22 Jun 2026 | — |
| BTIG | Thomas Shrader | Buy | 7 Aug 2026 | 39.00 USD |
| Deutsche Bank | David Hoang | Buy | 16 Jul 2026 | 35.00 USD |
| Evercore ISI | Michael G Difiore | Buy | 9 Sep 2026 | 33.00 USD |
| Goldman Sachs | Salveen Richter | Buy | 14 May 2026 | 42.00 USD |
| H.C. Wainwright | Andrew S Fein | Buy | 4 Nov 2026 | 42.00 USD |
| Jefferies | Andrew Tsai | Buy | 22 May 2026 | 40.00 USD |
| JPMorgan | Jessica Fye | Buy | 13 Jul 2026 | 29.00 USD |
| Leerink Partners | Marc Goodman | Buy | 8 Oct 2026 | 30.00 USD |
| Morgan Stanley | Matthew Harrison | Buy | 23 Jul 2026 | 36.00 USD |
| Stifel | Paul Mattels | — | 22 Jun 2026 | 41.00 USD |
| TD Cowen | Joseph Thome | Buy | 15 Jun 2026 | — |
| UBS | Michael Yee | Buy | 7 Aug 2026 | 34.00 USD |
| Wedbush | Laura Chico | Buy | 19 Oct 2026 | 23.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| William Blair | Myles R Minter | Buy | 13 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:47 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.